An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells

被引:101
作者
Wickström, SA
Alitalo, K
Keski-Oja, J
机构
[1] Univ Helsinki, Biomedicum Helsinki, Haartman Inst, Dept Pathol,Cell Biol Lab, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Biomedicum Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[4] Univ Helsinki, Biomedicum Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland
[5] Univ Helsinki Hosp, FIN-00014 Helsinki, Finland
关键词
D O I
10.1074/jbc.M312921200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endostatin, the C-terminal fragment of collagen XVIII, is a potent inhibitor of angiogenesis and endothelial cell migration. To define its critical cell interaction domains we used endostatin-derived synthetic peptides containing surface-exposed sequences. We observed that, when immobilized, an arginine-rich peptide of 11 amino acids from its N terminus efficiently promoted endothelial cell adhesion through beta(1) integrin- and heparin-dependent mechanisms. In addition, the peptide induced the formation of membrane ruffles and focal contacts. In the soluble form, the peptide inhibited basic fibroblast growth factor-induced directional migration and tubular morphogenesis of microvascular endothelial cells. Accordingly, the peptide induced the loss of focal adhesions and actin stress fibers in these cells. Substitution of the arginine residues with alanines resulted in the loss of these properties. In the current study we describe a putative integrin- binding sequence with anti-migratory activity within endostatin.
引用
收藏
页码:20178 / 20185
页数:8
相关论文
共 39 条
[1]   MOTILITY OF FIBRONECTIN RECEPTOR-DEFICIENT CELLS ON FIBRONECTIN AND VITRONECTIN - COLLABORATIVE INTERACTIONS AMONG INTEGRINS [J].
BAUER, JS ;
SCHREINER, CL ;
GIANCOTTI, FG ;
RUOSLAHTI, E ;
JULIANO, RL .
JOURNAL OF CELL BIOLOGY, 1992, 116 (02) :477-487
[2]   Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene [J].
Blezinger, P ;
Wang, JJ ;
Gondo, M ;
Quezada, A ;
Mehrens, D ;
French, M ;
Singhal, A ;
Sullivan, S ;
Rolland, A ;
Ralston, R ;
Min, W .
NATURE BIOTECHNOLOGY, 1999, 17 (04) :343-348
[3]   Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding [J].
Chang, Z ;
Choon, A ;
Friedl, A .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01) :71-76
[4]   Studies on the structure-activity relationship of endostatin: Synthesis of human endostatin peptides exhibiting potent antiangiogenic activities [J].
Chillemi, F ;
Francescato, P ;
Ragg, E ;
Cattaneo, MG ;
Pola, S ;
Vicentini, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) :4165-4172
[5]   Integrin-mediated signals regulated by members of the Rho family of GTPases [J].
Clark, EA ;
King, WG ;
Brugge, JS ;
Symons, M ;
Hynes, RO .
JOURNAL OF CELL BIOLOGY, 1998, 142 (02) :573-586
[6]  
Dhanabal M, 1999, CANCER RES, V59, P189
[7]   Endostatin induces endothelial cell apoptosis [J].
Dhanabal, M ;
Ramchandran, R ;
Waterman, MJF ;
Lu, H ;
Knebelmann, B ;
Segal, M ;
Sukhatme, VP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) :11721-11726
[8]   Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis [J].
Dixelius, J ;
Larsson, H ;
Sasaki, T ;
Holmqvist, K ;
Lu, LG ;
Engström, Å ;
Timpl, R ;
Welsh, M ;
Claesson-Welsh, L .
BLOOD, 2000, 95 (11) :3403-3411
[9]  
Dixelius J, 2002, CANCER RES, V62, P1944
[10]   Integrin and growth factor receptor crosstalk [J].
Eliceiri, BP .
CIRCULATION RESEARCH, 2001, 89 (12) :1104-1110